{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T09:58:58Z","timestamp":1760954338397},"reference-count":19,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2000,1,1]],"date-time":"2000-01-01T00:00:00Z","timestamp":946684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Computer Methods and Programs in Biomedicine"],"published-print":{"date-parts":[[2000,1]]},"DOI":"10.1016\/s0169-2607(99)00028-0","type":"journal-article","created":{"date-parts":[[2002,7,25]],"date-time":"2002-07-25T08:08:03Z","timestamp":1027584483000},"page":"61-69","source":"Crossref","is-referenced-by-count":7,"title":["A program for the optimization of cyclosporine therapy using population kinetics modeling"],"prefix":"10.1016","volume":"61","author":[{"given":"A","family":"Ruggeri","sequence":"first","affiliation":[]},{"given":"M","family":"Martinelli","sequence":"additional","affiliation":[]}],"member":"78","reference":[{"key":"10.1016\/S0169-2607(99)00028-0_BIB1","first-page":"2583","article-title":"Clinical algorithms for cyclosporine management based on pathophysiologic constructs of nephrotoxicity","volume":"26","author":"Bennett","year":"1994","journal-title":"Transplant. Proc."},{"key":"10.1016\/S0169-2607(99)00028-0_BIB2","first-page":"2716","article-title":"Design and evaluation of a computer tool to aid early management of cyclosporine therapy after heart and heart\u2013lung transplantation","volume":"26","author":"Best","year":"1994","journal-title":"Transplant. Proc."},{"key":"10.1016\/S0169-2607(99)00028-0_BIB3","first-page":"200","article-title":"Application of Bayesian forecasting to predict appropriate cyclosporine dosing regimens for renal allograft recipients","volume":"18","author":"Kahan","year":"1986","journal-title":"Transplant. Proc."},{"key":"10.1016\/S0169-2607(99)00028-0_BIB4","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1097\/00007890-198604000-00009","article-title":"Demographic factors affecting the pharmacokinetics of cyclosporine estimated by radioimmunoassay","volume":"41","author":"Kahan","year":"1986","journal-title":"Transplantation"},{"key":"10.1016\/S0169-2607(99)00028-0_BIB5","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1097\/00007890-198511000-00001","article-title":"Individualization of cyclosporine therapy using pharmacokinetic and pharmacodynamic parameters","volume":"40","author":"Kahan","year":"1985","journal-title":"Transplantation"},{"key":"10.1016\/S0169-2607(99)00028-0_BIB6","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1097\/00007691-199310000-00005","article-title":"Individualizing drug dosage regimens: roles of population pharmacokinetic and dynamic models, Bayesian fitting, and adaptive control","volume":"15","author":"Jelliffe","year":"1993","journal-title":"Ther. Drug Monit."},{"key":"10.1016\/S0169-2607(99)00028-0_BIB7","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/BF00606661","article-title":"Pharmacokinetics of oral cyclosporin A (Sandimmun) in healthy subject","volume":"31","author":"Grevel","year":"1986","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/S0169-2607(99)00028-0_BIB8","first-page":"626P","article-title":"Pharmacokinetics of cyclosporine in the early\u2013post operative period following renal transplantation","volume":"26","author":"Niven","year":"1988","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/S0169-2607(99)00028-0_BIB9","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s002280050199","article-title":"How many patients and blood level are necessary for population pharmacokinetic analysis?","volume":"51","author":"Br\u00e9ant","year":"1996","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/S0169-2607(99)00028-0_BIB10","unstructured":"E.R. Carson, C. Cobelli, L. Finkelstein, The mathematical modeling of metabolic and endocrine systems, Wiley-Interscience, New York, 1983."},{"key":"10.1016\/S0169-2607(99)00028-0_BIB11","unstructured":"M. Davidian, D.M. Giltinan, Nonlinear models for repeated measurement data, Chapman & Hall, London, 1995."},{"key":"10.1016\/S0169-2607(99)00028-0_BIB12","doi-asserted-by":"crossref","first-page":"265","DOI":"10.3109\/03602538409015066","article-title":"Alternative approaches to estimation of population pharmacokinetic parameters: comparison with the nonlinear mixed-effects model","volume":"15","author":"Steimer","year":"1984","journal-title":"Drug Metab. Rev."},{"key":"10.1016\/S0169-2607(99)00028-0_BIB13","unstructured":"M. Davidian, A.R. Gallant, Nlmix: a program for maximum likelihood estimation of the nonlinear mixed effects model with a smooth random effects density. User\u2019s Guide."},{"key":"10.1016\/S0169-2607(99)00028-0_BIB14","unstructured":"ftp:\/\/ftp.econ.duke.edu\/home\/arg\/nlmix"},{"key":"10.1016\/S0169-2607(99)00028-0_BIB15","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1007\/BF01061470","article-title":"Smooth nonparametric maximum likelihood estimation for population parmacokinetics, with application to quinidine","volume":"20","author":"Davidian","year":"1992","journal-title":"J. Pharmacokin. Biopharm."},{"key":"10.1016\/S0169-2607(99)00028-0_BIB16","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1093\/biomet\/80.3.475","article-title":"The nonlinear mixed effects model with a smooth random effects density","volume":"80","author":"Davidian","year":"1993","journal-title":"Biometrika"},{"key":"10.1016\/S0169-2607(99)00028-0_BIB17","unstructured":"D.Z. D\u2019Argenio, A. Schumitzky, ADAPT II. User\u2019s guide to Release 4, Biomedical Simulations Resource, University of Southern California, LA, 1997."},{"key":"10.1016\/S0169-2607(99)00028-0_BIB18","unstructured":"http:\/\/www.usc.edu\/dept\/biomed\/BMSR\/Software\/adptmenu.html"},{"key":"10.1016\/S0169-2607(99)00028-0_BIB19","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1097\/00007691-199404000-00009","article-title":"Evaluation of Bayesian approach to the pharmacokinetics interpretation of cyclosporine concentrations in renal allograft patients","volume":"16","author":"Anderson","year":"1994","journal-title":"Ther. Drug Monit."}],"container-title":["Computer Methods and Programs in Biomedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169260799000280?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169260799000280?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,30]],"date-time":"2019-04-30T21:21:18Z","timestamp":1556659278000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0169260799000280"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,1]]},"references-count":19,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2000,1]]}},"alternative-id":["S0169260799000280"],"URL":"https:\/\/doi.org\/10.1016\/s0169-2607(99)00028-0","relation":{},"ISSN":["0169-2607"],"issn-type":[{"value":"0169-2607","type":"print"}],"subject":[],"published":{"date-parts":[[2000,1]]}}}